Report Overview
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global Bacteriophage Therapy market size was estimated at USD 32 million in 2023 and is projected to reach USD 73.02 million by 2032, exhibiting a CAGR of 9.60% during the forecast period.
North America Bacteriophage Therapy market size was estimated at USD 9.77 million in 2023, at a CAGR of 8.23% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Bacteriophage Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bacteriophage Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bacteriophage Therapy market in any manner.
Global Bacteriophage Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Armata Pharmaceuticals
Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix
Inc.
Phagelux Inc.
Nextbiotics
InnoPhage
Ltd
Locus Biosciences
Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro
Inc.
Adaptive Phage Therapeutics
Inc.
EnBiotix
Inc.
Intodeworld
Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation
Market Segmentation (by Type)
Oral
Topical
Parenteral
Market Segmentation (by Application)
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Bacteriophage Therapy Market
Overview of the regional outlook of the Bacteriophage Therapy Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Bacteriophage Therapy
1.2 Key Market Segments
1.2.1 Bacteriophage Therapy Segment by Type
1.2.2 Bacteriophage Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Bacteriophage Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Bacteriophage Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Bacteriophage Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Bacteriophage Therapy Market Competitive Landscape
3.1 Global Bacteriophage Therapy Sales by Manufacturers (2019-2025)
3.2 Global Bacteriophage Therapy Revenue Market Share by Manufacturers (2019-2025)
3.3 Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bacteriophage Therapy Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Bacteriophage Therapy Sales Sites, Area Served, Product Type
3.6 Bacteriophage Therapy Market Competitive Situation and Trends
3.6.1 Bacteriophage Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bacteriophage Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Bacteriophage Therapy Industry Chain Analysis
4.1 Bacteriophage Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Bacteriophage Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Bacteriophage Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bacteriophage Therapy Sales Market Share by Type (2019-2025)
6.3 Global Bacteriophage Therapy Market Size Market Share by Type (2019-2025)
6.4 Global Bacteriophage Therapy Price by Type (2019-2025)
7 Bacteriophage Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bacteriophage Therapy Market Sales by Application (2019-2025)
7.3 Global Bacteriophage Therapy Market Size (M USD) by Application (2019-2025)
7.4 Global Bacteriophage Therapy Sales Growth Rate by Application (2019-2025)
8 Bacteriophage Therapy Market Consumption by Region
8.1 Global Bacteriophage Therapy Sales by Region
8.1.1 Global Bacteriophage Therapy Sales by Region
8.1.2 Global Bacteriophage Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Bacteriophage Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bacteriophage Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bacteriophage Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bacteriophage Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bacteriophage Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Bacteriophage Therapy Market Production by Region
9.1 Global Production of Bacteriophage Therapy by Region (2019-2025)
9.2 Global Bacteriophage Therapy Revenue Market Share by Region (2019-2025)
9.3 Global Bacteriophage Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Bacteriophage Therapy Production
9.4.1 North America Bacteriophage Therapy Production Growth Rate (2019-2025)
9.4.2 North America Bacteriophage Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Bacteriophage Therapy Production
9.5.1 Europe Bacteriophage Therapy Production Growth Rate (2019-2025)
9.5.2 Europe Bacteriophage Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Bacteriophage Therapy Production (2019-2025)
9.6.1 Japan Bacteriophage Therapy Production Growth Rate (2019-2025)
9.6.2 Japan Bacteriophage Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Bacteriophage Therapy Production (2019-2025)
9.7.1 China Bacteriophage Therapy Production Growth Rate (2019-2025)
9.7.2 China Bacteriophage Therapy Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Armata Pharmaceuticals
10.1.1 Armata Pharmaceuticals Bacteriophage Therapy Basic Information
10.1.2 Armata Pharmaceuticals Bacteriophage Therapy Product Overview
10.1.3 Armata Pharmaceuticals Bacteriophage Therapy Product Market Performance
10.1.4 Armata Pharmaceuticals Business Overview
10.1.5 Armata Pharmaceuticals Bacteriophage Therapy SWOT Analysis
10.1.6 Armata Pharmaceuticals Recent Developments
10.2 Inc.
10.2.1 Inc. Bacteriophage Therapy Basic Information
10.2.2 Inc. Bacteriophage Therapy Product Overview
10.2.3 Inc. Bacteriophage Therapy Product Market Performance
10.2.4 Inc. Business Overview
10.2.5 Inc. Bacteriophage Therapy SWOT Analysis
10.2.6 Inc. Recent Developments
10.3 Eliava Biopreparations Ltd.
10.3.1 Eliava Biopreparations Ltd. Bacteriophage Therapy Basic Information
10.3.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Overview
10.3.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Market Performance
10.3.4 Eliava Biopreparations Ltd. Bacteriophage Therapy SWOT Analysis
10.3.5 Eliava Biopreparations Ltd. Business Overview
10.3.6 Eliava Biopreparations Ltd. Recent Developments
10.4 Pherecydes Pharma
10.4.1 Pherecydes Pharma Bacteriophage Therapy Basic Information
10.4.2 Pherecydes Pharma Bacteriophage Therapy Product Overview
10.4.3 Pherecydes Pharma Bacteriophage Therapy Product Market Performance
10.4.4 Pherecydes Pharma Business Overview
10.4.5 Pherecydes Pharma Recent Developments
10.5 Intralytix
10.5.1 Intralytix Bacteriophage Therapy Basic Information
10.5.2 Intralytix Bacteriophage Therapy Product Overview
10.5.3 Intralytix Bacteriophage Therapy Product Market Performance
10.5.4 Intralytix Business Overview
10.5.5 Intralytix Recent Developments
10.6 Inc.
10.6.1 Inc. Bacteriophage Therapy Basic Information
10.6.2 Inc. Bacteriophage Therapy Product Overview
10.6.3 Inc. Bacteriophage Therapy Product Market Performance
10.6.4 Inc. Business Overview
10.6.5 Inc. Recent Developments
10.7 Phagelux Inc.
10.7.1 Phagelux Inc. Bacteriophage Therapy Basic Information
10.7.2 Phagelux Inc. Bacteriophage Therapy Product Overview
10.7.3 Phagelux Inc. Bacteriophage Therapy Product Market Performance
10.7.4 Phagelux Inc. Business Overview
10.7.5 Phagelux Inc. Recent Developments
10.8 Nextbiotics
10.8.1 Nextbiotics Bacteriophage Therapy Basic Information
10.8.2 Nextbiotics Bacteriophage Therapy Product Overview
10.8.3 Nextbiotics Bacteriophage Therapy Product Market Performance
10.8.4 Nextbiotics Business Overview
10.8.5 Nextbiotics Recent Developments
10.9 InnoPhage
10.9.1 InnoPhage Bacteriophage Therapy Basic Information
10.9.2 InnoPhage Bacteriophage Therapy Product Overview
10.9.3 InnoPhage Bacteriophage Therapy Product Market Performance
10.9.4 InnoPhage Business Overview
10.9.5 InnoPhage Recent Developments
10.10 Ltd
10.10.1 Ltd Bacteriophage Therapy Basic Information
10.10.2 Ltd Bacteriophage Therapy Product Overview
10.10.3 Ltd Bacteriophage Therapy Product Market Performance
10.10.4 Ltd Business Overview
10.10.5 Ltd Recent Developments
10.11 Locus Biosciences
10.11.1 Locus Biosciences Bacteriophage Therapy Basic Information
10.11.2 Locus Biosciences Bacteriophage Therapy Product Overview
10.11.3 Locus Biosciences Bacteriophage Therapy Product Market Performance
10.11.4 Locus Biosciences Business Overview
10.11.5 Locus Biosciences Recent Developments
10.12 Inc.
10.12.1 Inc. Bacteriophage Therapy Basic Information
10.12.2 Inc. Bacteriophage Therapy Product Overview
10.12.3 Inc. Bacteriophage Therapy Product Market Performance
10.12.4 Inc. Business Overview
10.12.5 Inc. Recent Developments
10.13 TechnoPhage
10.13.1 TechnoPhage Bacteriophage Therapy Basic Information
10.13.2 TechnoPhage Bacteriophage Therapy Product Overview
10.13.3 TechnoPhage Bacteriophage Therapy Product Market Performance
10.13.4 TechnoPhage Business Overview
10.13.5 TechnoPhage Recent Developments
10.14 Eligo Bioscience SA
10.14.1 Eligo Bioscience SA Bacteriophage Therapy Basic Information
10.14.2 Eligo Bioscience SA Bacteriophage Therapy Product Overview
10.14.3 Eligo Bioscience SA Bacteriophage Therapy Product Market Performance
10.14.4 Eligo Bioscience SA Business Overview
10.14.5 Eligo Bioscience SA Recent Developments
10.15 Phagomed Biopharma GmbH.
10.15.1 Phagomed Biopharma GmbH. Bacteriophage Therapy Basic Information
10.15.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Overview
10.15.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Market Performance
10.15.4 Phagomed Biopharma GmbH. Business Overview
10.15.5 Phagomed Biopharma GmbH. Recent Developments
10.16 PhagePro
10.16.1 PhagePro Bacteriophage Therapy Basic Information
10.16.2 PhagePro Bacteriophage Therapy Product Overview
10.16.3 PhagePro Bacteriophage Therapy Product Market Performance
10.16.4 PhagePro Business Overview
10.16.5 PhagePro Recent Developments
10.17 Inc.
10.17.1 Inc. Bacteriophage Therapy Basic Information
10.17.2 Inc. Bacteriophage Therapy Product Overview
10.17.3 Inc. Bacteriophage Therapy Product Market Performance
10.17.4 Inc. Business Overview
10.17.5 Inc. Recent Developments
10.18 Adaptive Phage Therapeutics
10.18.1 Adaptive Phage Therapeutics Bacteriophage Therapy Basic Information
10.18.2 Adaptive Phage Therapeutics Bacteriophage Therapy Product Overview
10.18.3 Adaptive Phage Therapeutics Bacteriophage Therapy Product Market Performance
10.18.4 Adaptive Phage Therapeutics Business Overview
10.18.5 Adaptive Phage Therapeutics Recent Developments
10.19 Inc.
10.19.1 Inc. Bacteriophage Therapy Basic Information
10.19.2 Inc. Bacteriophage Therapy Product Overview
10.19.3 Inc. Bacteriophage Therapy Product Market Performance
10.19.4 Inc. Business Overview
10.19.5 Inc. Recent Developments
10.20 EnBiotix
10.20.1 EnBiotix Bacteriophage Therapy Basic Information
10.20.2 EnBiotix Bacteriophage Therapy Product Overview
10.20.3 EnBiotix Bacteriophage Therapy Product Market Performance
10.20.4 EnBiotix Business Overview
10.20.5 EnBiotix Recent Developments
10.21 Inc.
10.21.1 Inc. Bacteriophage Therapy Basic Information
10.21.2 Inc. Bacteriophage Therapy Product Overview
10.21.3 Inc. Bacteriophage Therapy Product Market Performance
10.21.4 Inc. Business Overview
10.21.5 Inc. Recent Developments
10.22 Intodeworld
10.22.1 Intodeworld Bacteriophage Therapy Basic Information
10.22.2 Intodeworld Bacteriophage Therapy Product Overview
10.22.3 Intodeworld Bacteriophage Therapy Product Market Performance
10.22.4 Intodeworld Business Overview
10.22.5 Intodeworld Recent Developments
10.23 Inc.
10.23.1 Inc. Bacteriophage Therapy Basic Information
10.23.2 Inc. Bacteriophage Therapy Product Overview
10.23.3 Inc. Bacteriophage Therapy Product Market Performance
10.23.4 Inc. Business Overview
10.23.5 Inc. Recent Developments
10.24 BiomX Ltd.
10.24.1 BiomX Ltd. Bacteriophage Therapy Basic Information
10.24.2 BiomX Ltd. Bacteriophage Therapy Product Overview
10.24.3 BiomX Ltd. Bacteriophage Therapy Product Market Performance
10.24.4 BiomX Ltd. Business Overview
10.24.5 BiomX Ltd. Recent Developments
10.25 Phi Therapeutics
10.25.1 Phi Therapeutics Bacteriophage Therapy Basic Information
10.25.2 Phi Therapeutics Bacteriophage Therapy Product Overview
10.25.3 Phi Therapeutics Bacteriophage Therapy Product Market Performance
10.25.4 Phi Therapeutics Business Overview
10.25.5 Phi Therapeutics Recent Developments
10.26 Fixed-phage Ltd.
10.26.1 Fixed-phage Ltd. Bacteriophage Therapy Basic Information
10.26.2 Fixed-phage Ltd. Bacteriophage Therapy Product Overview
10.26.3 Fixed-phage Ltd. Bacteriophage Therapy Product Market Performance
10.26.4 Fixed-phage Ltd. Business Overview
10.26.5 Fixed-phage Ltd. Recent Developments
10.27 Micreos BV
10.27.1 Micreos BV Bacteriophage Therapy Basic Information
10.27.2 Micreos BV Bacteriophage Therapy Product Overview
10.27.3 Micreos BV Bacteriophage Therapy Product Market Performance
10.27.4 Micreos BV Business Overview
10.27.5 Micreos BV Recent Developments
10.28 ContraFect Corporation
10.28.1 ContraFect Corporation Bacteriophage Therapy Basic Information
10.28.2 ContraFect Corporation Bacteriophage Therapy Product Overview
10.28.3 ContraFect Corporation Bacteriophage Therapy Product Market Performance
10.28.4 ContraFect Corporation Business Overview
10.28.5 ContraFect Corporation Recent Developments
11 Bacteriophage Therapy Market Forecast by Region
11.1 Global Bacteriophage Therapy Market Size Forecast
11.2 Global Bacteriophage Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Bacteriophage Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Bacteriophage Therapy Market Size Forecast by Region
11.2.4 South America Bacteriophage Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Bacteriophage Therapy by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Bacteriophage Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Bacteriophage Therapy by Type (2025-2032)
12.1.2 Global Bacteriophage Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Bacteriophage Therapy by Type (2025-2032)
12.2 Global Bacteriophage Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Bacteriophage Therapy Sales (K Units) Forecast by Application
12.2.2 Global Bacteriophage Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Bacteriophage Therapy Market Size Comparison by Region (M USD)
Table 5. Global Bacteriophage Therapy Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Bacteriophage Therapy Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Bacteriophage Therapy Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Bacteriophage Therapy Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2022)
Table 10. Global Market Bacteriophage Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Bacteriophage Therapy Sales Sites and Area Served
Table 12. Manufacturers Bacteriophage Therapy Product Type
Table 13. Global Bacteriophage Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Bacteriophage Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Bacteriophage Therapy Market Challenges
Table 22. Global Bacteriophage Therapy Sales by Type (K Units)
Table 23. Global Bacteriophage Therapy Market Size by Type (M USD)
Table 24. Global Bacteriophage Therapy Sales (K Units) by Type (2019-2025)
Table 25. Global Bacteriophage Therapy Sales Market Share by Type (2019-2025)
Table 26. Global Bacteriophage Therapy Market Size (M USD) by Type (2019-2025)
Table 27. Global Bacteriophage Therapy Market Size Share by Type (2019-2025)
Table 28. Global Bacteriophage Therapy Price (USD/Unit) by Type (2019-2025)
Table 29. Global Bacteriophage Therapy Sales (K Units) by Application
Table 30. Global Bacteriophage Therapy Market Size by Application
Table 31. Global Bacteriophage Therapy Sales by Application (2019-2025) & (K Units)
Table 32. Global Bacteriophage Therapy Sales Market Share by Application (2019-2025)
Table 33. Global Bacteriophage Therapy Sales by Application (2019-2025) & (M USD)
Table 34. Global Bacteriophage Therapy Market Share by Application (2019-2025)
Table 35. Global Bacteriophage Therapy Sales Growth Rate by Application (2019-2025)
Table 36. Global Bacteriophage Therapy Sales by Region (2019-2025) & (K Units)
Table 37. Global Bacteriophage Therapy Sales Market Share by Region (2019-2025)
Table 38. North America Bacteriophage Therapy Sales by Country (2019-2025) & (K Units)
Table 39. Europe Bacteriophage Therapy Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Bacteriophage Therapy Sales by Region (2019-2025) & (K Units)
Table 41. South America Bacteriophage Therapy Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Bacteriophage Therapy Sales by Region (2019-2025) & (K Units)
Table 43. Global Bacteriophage Therapy Production (K Units) by Region (2019-2025)
Table 44. Global Bacteriophage Therapy Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Bacteriophage Therapy Revenue Market Share by Region (2019-2025)
Table 46. Global Bacteriophage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Bacteriophage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Bacteriophage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Bacteriophage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Bacteriophage Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Armata Pharmaceuticals Bacteriophage Therapy Basic Information
Table 52. Armata Pharmaceuticals Bacteriophage Therapy Product Overview
Table 53. Armata Pharmaceuticals Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Armata Pharmaceuticals Business Overview
Table 55. Armata Pharmaceuticals Bacteriophage Therapy SWOT Analysis
Table 56. Armata Pharmaceuticals Recent Developments
Table 57. Inc. Bacteriophage Therapy Basic Information
Table 58. Inc. Bacteriophage Therapy Product Overview
Table 59. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Inc. Business Overview
Table 61. Inc. Bacteriophage Therapy SWOT Analysis
Table 62. Inc. Recent Developments
Table 63. Eliava Biopreparations Ltd. Bacteriophage Therapy Basic Information
Table 64. Eliava Biopreparations Ltd. Bacteriophage Therapy Product Overview
Table 65. Eliava Biopreparations Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Eliava Biopreparations Ltd. Bacteriophage Therapy SWOT Analysis
Table 67. Eliava Biopreparations Ltd. Business Overview
Table 68. Eliava Biopreparations Ltd. Recent Developments
Table 69. Pherecydes Pharma Bacteriophage Therapy Basic Information
Table 70. Pherecydes Pharma Bacteriophage Therapy Product Overview
Table 71. Pherecydes Pharma Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Pherecydes Pharma Business Overview
Table 73. Pherecydes Pharma Recent Developments
Table 74. Intralytix Bacteriophage Therapy Basic Information
Table 75. Intralytix Bacteriophage Therapy Product Overview
Table 76. Intralytix Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Intralytix Business Overview
Table 78. Intralytix Recent Developments
Table 79. Inc. Bacteriophage Therapy Basic Information
Table 80. Inc. Bacteriophage Therapy Product Overview
Table 81. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Inc. Business Overview
Table 83. Inc. Recent Developments
Table 84. Phagelux Inc. Bacteriophage Therapy Basic Information
Table 85. Phagelux Inc. Bacteriophage Therapy Product Overview
Table 86. Phagelux Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Phagelux Inc. Business Overview
Table 88. Phagelux Inc. Recent Developments
Table 89. Nextbiotics Bacteriophage Therapy Basic Information
Table 90. Nextbiotics Bacteriophage Therapy Product Overview
Table 91. Nextbiotics Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Nextbiotics Business Overview
Table 93. Nextbiotics Recent Developments
Table 94. InnoPhage Bacteriophage Therapy Basic Information
Table 95. InnoPhage Bacteriophage Therapy Product Overview
Table 96. InnoPhage Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. InnoPhage Business Overview
Table 98. InnoPhage Recent Developments
Table 99. Ltd Bacteriophage Therapy Basic Information
Table 100. Ltd Bacteriophage Therapy Product Overview
Table 101. Ltd Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Ltd Business Overview
Table 103. Ltd Recent Developments
Table 104. Locus Biosciences Bacteriophage Therapy Basic Information
Table 105. Locus Biosciences Bacteriophage Therapy Product Overview
Table 106. Locus Biosciences Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Locus Biosciences Business Overview
Table 108. Locus Biosciences Recent Developments
Table 109. Inc. Bacteriophage Therapy Basic Information
Table 110. Inc. Bacteriophage Therapy Product Overview
Table 111. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Inc. Business Overview
Table 113. Inc. Recent Developments
Table 114. TechnoPhage Bacteriophage Therapy Basic Information
Table 115. TechnoPhage Bacteriophage Therapy Product Overview
Table 116. TechnoPhage Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. TechnoPhage Business Overview
Table 118. TechnoPhage Recent Developments
Table 119. Eligo Bioscience SA Bacteriophage Therapy Basic Information
Table 120. Eligo Bioscience SA Bacteriophage Therapy Product Overview
Table 121. Eligo Bioscience SA Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Eligo Bioscience SA Business Overview
Table 123. Eligo Bioscience SA Recent Developments
Table 124. Phagomed Biopharma GmbH. Bacteriophage Therapy Basic Information
Table 125. Phagomed Biopharma GmbH. Bacteriophage Therapy Product Overview
Table 126. Phagomed Biopharma GmbH. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Phagomed Biopharma GmbH. Business Overview
Table 128. Phagomed Biopharma GmbH. Recent Developments
Table 129. PhagePro Bacteriophage Therapy Basic Information
Table 130. PhagePro Bacteriophage Therapy Product Overview
Table 131. PhagePro Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 132. PhagePro Business Overview
Table 133. PhagePro Recent Developments
Table 134. Inc. Bacteriophage Therapy Basic Information
Table 135. Inc. Bacteriophage Therapy Product Overview
Table 136. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 137. Inc. Business Overview
Table 138. Inc. Recent Developments
Table 139. Adaptive Phage Therapeutics Bacteriophage Therapy Basic Information
Table 140. Adaptive Phage Therapeutics Bacteriophage Therapy Product Overview
Table 141. Adaptive Phage Therapeutics Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 142. Adaptive Phage Therapeutics Business Overview
Table 143. Adaptive Phage Therapeutics Recent Developments
Table 144. Inc. Bacteriophage Therapy Basic Information
Table 145. Inc. Bacteriophage Therapy Product Overview
Table 146. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 147. Inc. Business Overview
Table 148. Inc. Recent Developments
Table 149. EnBiotix Bacteriophage Therapy Basic Information
Table 150. EnBiotix Bacteriophage Therapy Product Overview
Table 151. EnBiotix Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 152. EnBiotix Business Overview
Table 153. EnBiotix Recent Developments
Table 154. Inc. Bacteriophage Therapy Basic Information
Table 155. Inc. Bacteriophage Therapy Product Overview
Table 156. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 157. Inc. Business Overview
Table 158. Inc. Recent Developments
Table 159. Intodeworld Bacteriophage Therapy Basic Information
Table 160. Intodeworld Bacteriophage Therapy Product Overview
Table 161. Intodeworld Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 162. Intodeworld Business Overview
Table 163. Intodeworld Recent Developments
Table 164. Inc. Bacteriophage Therapy Basic Information
Table 165. Inc. Bacteriophage Therapy Product Overview
Table 166. Inc. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 167. Inc. Business Overview
Table 168. Inc. Recent Developments
Table 169. BiomX Ltd. Bacteriophage Therapy Basic Information
Table 170. BiomX Ltd. Bacteriophage Therapy Product Overview
Table 171. BiomX Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 172. BiomX Ltd. Business Overview
Table 173. BiomX Ltd. Recent Developments
Table 174. Phi Therapeutics Bacteriophage Therapy Basic Information
Table 175. Phi Therapeutics Bacteriophage Therapy Product Overview
Table 176. Phi Therapeutics Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 177. Phi Therapeutics Business Overview
Table 178. Phi Therapeutics Recent Developments
Table 179. Fixed-phage Ltd. Bacteriophage Therapy Basic Information
Table 180. Fixed-phage Ltd. Bacteriophage Therapy Product Overview
Table 181. Fixed-phage Ltd. Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 182. Fixed-phage Ltd. Business Overview
Table 183. Fixed-phage Ltd. Recent Developments
Table 184. Micreos BV Bacteriophage Therapy Basic Information
Table 185. Micreos BV Bacteriophage Therapy Product Overview
Table 186. Micreos BV Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 187. Micreos BV Business Overview
Table 188. Micreos BV Recent Developments
Table 189. ContraFect Corporation Bacteriophage Therapy Basic Information
Table 190. ContraFect Corporation Bacteriophage Therapy Product Overview
Table 191. ContraFect Corporation Bacteriophage Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 192. ContraFect Corporation Business Overview
Table 193. ContraFect Corporation Recent Developments
Table 194. Global Bacteriophage Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 195. Global Bacteriophage Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 196. North America Bacteriophage Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 197. North America Bacteriophage Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 198. Europe Bacteriophage Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 199. Europe Bacteriophage Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 200. Asia Pacific Bacteriophage Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 201. Asia Pacific Bacteriophage Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 202. South America Bacteriophage Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 203. South America Bacteriophage Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 204. Middle East and Africa Bacteriophage Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 205. Middle East and Africa Bacteriophage Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 206. Global Bacteriophage Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 207. Global Bacteriophage Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 208. Global Bacteriophage Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 209. Global Bacteriophage Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 210. Global Bacteriophage Therapy Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Bacteriophage Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Bacteriophage Therapy Market Size (M USD), 2019-2032
Figure 5. Global Bacteriophage Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Bacteriophage Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Bacteriophage Therapy Market Size by Country (M USD)
Figure 11. Bacteriophage Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Bacteriophage Therapy Revenue Share by Manufacturers in 2023
Figure 13. Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Bacteriophage Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Bacteriophage Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Bacteriophage Therapy Market Share by Type
Figure 18. Sales Market Share of Bacteriophage Therapy by Type (2019-2025)
Figure 19. Sales Market Share of Bacteriophage Therapy by Type in 2023
Figure 20. Market Size Share of Bacteriophage Therapy by Type (2019-2025)
Figure 21. Market Size Market Share of Bacteriophage Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Bacteriophage Therapy Market Share by Application
Figure 24. Global Bacteriophage Therapy Sales Market Share by Application (2019-2025)
Figure 25. Global Bacteriophage Therapy Sales Market Share by Application in 2023
Figure 26. Global Bacteriophage Therapy Market Share by Application (2019-2025)
Figure 27. Global Bacteriophage Therapy Market Share by Application in 2023
Figure 28. Global Bacteriophage Therapy Sales Growth Rate by Application (2019-2025)
Figure 29. Global Bacteriophage Therapy Sales Market Share by Region (2019-2025)
Figure 30. North America Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Bacteriophage Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Bacteriophage Therapy Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Bacteriophage Therapy Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Bacteriophage Therapy Sales Market Share by Country in 2023
Figure 37. Germany Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Bacteriophage Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Bacteriophage Therapy Sales Market Share by Region in 2023
Figure 44. China Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Bacteriophage Therapy Sales and Growth Rate (K Units)
Figure 50. South America Bacteriophage Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Bacteriophage Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Bacteriophage Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Bacteriophage Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Bacteriophage Therapy Production Market Share by Region (2019-2025)
Figure 62. North America Bacteriophage Therapy Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Bacteriophage Therapy Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Bacteriophage Therapy Production (K Units) Growth Rate (2019-2025)
Figure 65. China Bacteriophage Therapy Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Bacteriophage Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Bacteriophage Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Bacteriophage Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Bacteriophage Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Bacteriophage Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Bacteriophage Therapy Market Share Forecast by Application (2025-2032)
